Bioconjugates for Cancer Prevention: Opportunities for Impact

Thumbnail Image

Files

lavikminasian2024bioconjugatesforcancerpreventionopportunitiesforimpact.pdf (2.68 MB)

Links to Files

https://pubs.acs.org/doi/full/10.1021/acs.bioconjchem.4c00283

Permanent Link

https://doi.org/10.1021/acs.bioconjchem.4c00283
 http://hdl.handle.net/11603/38022

Collections

UMBC College of Engineering and Information Technology Dean's Office
UMBC Chemical, Biochemical & Environmental Engineering Department
UMBC Faculty Collection

Author/Creator

Author/Creator ORCID

https://orcid.org/0000-0002-0644-744X

Date

2024-08-21

Type of Work

journal articles
Text

Department

Program

Citation of Original Publication

Lavik, Erin, and Lori Minasian. “Bioconjugates for Cancer Prevention: Opportunities for Impact.” Bioconjugate Chemistry 35, no. 8 (August 21, 2024): 1148–53. https://doi.org/10.1021/acs.bioconjchem.4c00283

Rights

This work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
Public Domain

Subjects

Abstract

Cancer prevention encompasses both screening strategies to find cancers early when they are likely to be most treatable and prevention and interception strategies to reduce the risk of developing cancers. Bioconjugates, here defined broadly as materials and molecules that have synthetic and biological components, have roles to play across the cancer-prevention spectrum. In particular, bioconjugates may be developed as affordable, accessible, and effective screening strategies or as novel vaccines and drugs to reduce one’s risk of developing cancers. Developmental programs are available for taking novel technologies and evaluating them for clinical use in cancer screening and prevention. While a variety of different challenges exist in implementing cancer-prevention interventions, a thoughtful approach to bioconjugates could improve the delivery and acceptability of the interventions.